Intracellular Th Stock Investor Sentiment

ITCI Stock  USD 128.25  0.21  0.16%   
Under 54% of Intracellular's traders are presently thinking to get in. The analysis of overall sentiment of trading Intracellular Th stock suggests that some investors are interested at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.

Comfort Level 54

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Intracellular's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Intracellular Th.
65.0%
43.0%
0.0%

Intracellular Historical Sentiment

Although Intracellular's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Intracellular, such as negative comments on social media and news outlets, may cause fear in the market and push Intracellular's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Intracellular.
  

Intracellular Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
60.1%
57.5%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Intracellular Th Historical Investor Sentiment

Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
News FrequencyInvestor Sentiment
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Intracellular news discussions. The higher the estimate score, the more favorable the investor's outlook on Intracellular.

Intracellular Maximum Pain Price Across May 16th 2025 Option Contracts

Intracellular's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Intracellular close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Intracellular's options.
Calls PricePuts Price
a day ago at thelincolnianonline.com         
Phocas Financial Corp. Sells 16,348 Shares of Intra-Cellular Therapies, Inc.
news
3 days ago at businesswire.com         
ITCI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc...
businesswire News
3 days ago at businesswire.com         
ITCI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc...
businesswire News
3 days ago at gurufocus.com         
Intra-Cellular Therapies Inc Under Investigation for Proposed Sale to Johnson Johnson
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Is Johnson Johnson the Best DRIP Stock to Own Now?
Yahoo News
few days ago at thelincolnianonline.com         
Title Intra-Cellular Therapies Reveals Year-End Unaudited Financials, Caplytas Remarkable Performanc...
news
few days ago at thelincolnianonline.com         
Intra-Cellular Therapies Stock Rating Lowered by Mizuho
news
few days ago at finance.yahoo.com         
Disposition of 7009 shares by Marcus Joel S of Intracellular at 63.79 subject to Rule 16b-3
Yahoo News
few days ago at gurufocus.com         
Intra-Cellular Therapies Inc Reports Strong Financial Growth and Pipeline Advancements
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Alberta Investment Management Corp Sells 4,500 Shares of Intra-Cellular Therapies, Inc.
news
few days ago at gurufocus.com         
Decoding Intra-Cellular Therapies Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
Intra-Cellular Q4 Earnings Snapshot
Yahoo News
six days ago at thelincolnianonline.com         
Intra-Cellular Therapies Given Hold Rating at Needham Company LLC
news
six days ago at seekingalpha.com         
Intra-Cellular Therapies GAAP EPS of -0.16 misses by 0.04, revenue of 199.22M beats by 5.93M
seekingalpha News
six days ago at gurufocus.com         
Intra-Cellular Therapies Inc Q4 Earnings Revenue Surpasses Estimates at 199. ...
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Intracellular that are available to investors today. That information is available publicly through Intracellular media outlets and privately through word of mouth or via Intracellular internal channels. However, regardless of the origin, that massive amount of Intracellular data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Intracellular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intracellular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intracellular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intracellular alpha.

Intracellular Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15123456789101112Dec2025Feb 01020304050
JavaScript chart by amCharts 3.21.15Intracellular Th Intracellular Th Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Disposition of 51697 shares by Sharon Mates of Intracellular at 12.73 subject to Rule 16b-3
12/05/2024
2
JNJ, GSK, LLY Announce MA Deals at JP Morgan Conference
01/14/2025
3
JJ beats quarterly sales and profit estimates on cancer drug sales
01/22/2025
4
Disposition of 4730 shares by Durgam Suresh K. of Intracellular at 127.0 subject to Rule 16b-3
01/31/2025
5
Acquisition by Mark Neumann of 11017 shares of Intracellular subject to Rule 16b-3
02/04/2025
6
Deep Track Capital, LP Reduces Stake in Nurix Therapeutics Inc
02/14/2025
7
Axsomes AXS-05 In Alzheimers Agitation Could Be Billion Dollar Opportunity, Says Analyst
02/18/2025
8
Intra-Cellular Therapies Sets New 1-Year High Time to Buy
02/19/2025
9
Intra-Cellular Therapies GAAP EPS of -0.16 misses by 0.04, revenue of 199.22M beats by 5.93M
02/21/2025
10
Title Intra-Cellular Therapies Reveals Year-End Unaudited Financials, Caplytas Remarkable Performance Key Highlight
02/24/2025
11
ITCI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
02/25/2025
12
Phocas Financial Corp. Sells 16,348 Shares of Intra-Cellular Therapies, Inc.
02/27/2025

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories